Cash Flow from Operating Activities (Quarterly)

Cash Flow from Operating Activities: A company's cash flows from operations.

Bioventus Inc. (BVS) had Cash Flow from Operating Activities of $28.81M for the most recently reported fiscal quarter, ending 2026-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2026-06-30

Income Statement Financials
Revenue	$153.21M
Net Income	$33.44M
Cost of Goods Sold	$47.54M
Gross Profit	$105.67M
Operating Expenses	$134.08M
Operating Income	$19.13M
Non-Operating Income/Expense	$-3.82M
Pre-Tax Income	$15.31M
Normalized Pre-Tax Income	$15.31M
Income after Taxes	$36.20M
Income from Continuous Operations	$36.20M
Consolidated Net Income/Loss	$36.20M
Normalized Income after Taxes	$36.20M
EBIT	$19.13M
EBITDA	$30.07M
Weighted-Average Shares Outstanding (Basic)	67.87M
Weighted-Average Shares Outstanding (Diluted)	70.84M
Earnings per Share (EPS) (Basic)	$0.49
Earnings per Share (EPS) (Diluted)	$0.47
Balance Sheet Financials
Current Assets	$257.53M
Property, Plant, and Equipment	$20.53M
Long-Term Assets	$415.82M
Total Assets	$673.35M
Current Liabilities	$152.45M
Long-Term Debt	$229.70M
Long-Term Liabilities	$243.48M
Total Liabilities	$395.93M
Common Equity	$277.41M
Tangible Shareholders Equity	$-81.10M
Shareholders Equity	$277.41M
Common Shares Outstanding	84.00M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$28.81M
Cash Flow from Investing Activities	$-3.03M
Cash Flow from Financial Activities	$-46.58M
Beginning Cash	$51.24M
End Cash	$29.46M
Increase/Decrease in Cash	$-21.78M
Stock-Based Compensation	$8.30M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.69
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.45
Debt to Equity Ratio	0.90
Gross Margin	68.97%
Operating Margin	12.48%
EBIT Margin	12.48%
EBITDA Margin	--
Pre-Tax Profit Margin	9.99%
Profit Margin	21.83%
Free Cash Flow	$27.27M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.23
Inventory Turnover	0.60
Receiveable Turnover	1.11
Days Sales in Receivables	81.30
Return on Equity	13.05%
Return on Tangible Equity	-44.64%
Return on Assets	5.38%
Return on Investments	7.14%
Book Value Per Share	$3.30
Free Cash Flow per Share	$0.39
Operating Cash Flow per Share	$0.41

Data from Zacks Investment Research, Inc.